Imprimis Pharma Q2 results


Imprimis Pharmaceuticals (IMMY +2.3%) Q2 results: Revenues: $0.7M (+999%); Net Loss: ($2.6M) (-17.0%); Loss Per Share: ($0.28) (-12.0%); Quick Assets: $12.1M (-14.8%); Cash Burn: ($1.5M).

No financial guidance given.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs